Polymorphism in the gene encoding the apical membrane antigen-1 (AMA-1) of Plasmodium falciparum. X. Asembo Bay Cohort Project
Introduction
Malaria is arguably one of the most important parasitic diseases in the world. Today more than 40% of the world's population lives in areas at risk for malaria. Each year there are between 500–600 million cases and 2–3 million deaths attributed to malaria most of which are of young children in sub-Saharan Africa [1]. While antimalarial drugs, insecticides, and bednets are being used against this disease, there is a realization that an effective vaccine is required for the control of malaria.
Different complementary approaches to vaccine development are being undertaken in several laboratories. However, irrespective of the approach, a common concern is the nature and extent of genetic diversity in natural populations of malaria parasites [2]. The obvious question is whether the vaccine-elicited immune response will be equally effective against all the genetic variants of the parasite, and how quickly resistance to the vaccine will develop.
In malaria, the issue of diversity is compounded by the multistage nature of the parasite. We have undertaken a comprehensive study to determine the genetic diversity of Plasmodium falciparum parasites from an area of high malaria transmission in western Kenya [3]. Our interest is also to compare it with the genetic diversity found in natural populations of P. falciparum from other geographic regions. For this purpose, we have included parasite isolates from Venezuela, Thailand, and India.
In this study, we describe the diversity of the gene encoding the apical membrane antigen-1 (AMA-1 gene). The AMA-1, also known as PF83, is a protein of 622 residues and a molecular weight of 83 kDa with three major domains defined by eigth disulfide bonds [4], [5]. This antigen first appears in the apical complex and then migrates to the merozoite's surface. Data from animal models suggests that this protein elicits protective immune responses [4], [6], [7]. We have earlier shown that synthetic peptides complementary to the putative T-cell determinants of AMA-1 are recognized by PBMCs from persons naturally exposed to malaria parasites in western Kenya [8].
In an earlier study of genetic diversity, which only focused on parasites from western Kenya, we reported that the AMA-1 was a conserved antigen as compared with other blood-stage antigens [9], [10]. Conversely, Marshall et al. [11] reported the presence of several alleles, suggesting that this antigen gene had high levels of genetic diversity. Unfortunately, the terms ‘low’ or ‘high’ do not have any genetic meaning. For this reason, we have striven to incorporate appropriate analytical tools in studies of genetic diversity [10].
Based on enzyme restriction sites, four allele families have been proposed for AMA-1 using a hypervariable region (HVR) [12]. The HVR was originally reported by Thomas et al. [13] between residues 160 and 210. However, others have defined the HVR as a larger portion in the domain I [5]; thus defining it between residues 138 and 307 [11], or residues 148–337 [12]. Oliveira et al. [9] subdivided the AMA-1 into 12 segments or blocks based on their level of polymorphism. The block 4 sensu Oliveira et al. [7] is a segment of 46 residues that overlaps with the HVR [9], [13].
This study is a comprehensive analysis of the diversity of the gene encoding the AMA-1 protein using primary isolates of P. falciparum. We have taken an approach to obtain a limited set of sequences from different geographic locations, which increases the probability of sampling the most divergent alleles in order to infer the history and processes involved in the evolution of the observed polymorphism [14]. A total of 28 complete sequences of P. falciparum were obtained from Kenya, Thailand, India, and Venezuela field isolates. The homologous gene in Plasmodium reichenowi, which is the closest related species to P. falciparum, was characterized for comparative analysis [15], [16]. Our P. reichenowi sequence differs in two nucleotide substitutions from the one available in GeneBank under the accession number AJ25087 [17].
Section snippets
Materials and methods
The parasite DNA used in this study was obtained from field isolates from Kenya, India, Thailand, and Venezuela. The gene encoding the AMA-1 protein was amplified by polymerase chain reaction (PCR) using specific primers [9]. The amplification conditions were as follows, first, 1 min at 94°C, followed by 30 cycles with 0.5 min of denaturation at 94°C, annealing at 40°C for 0.5 min, and elongation at 72°C for 1.5 min. After 30 cycles, a final elongation step at 72°C for 3.0 min was carried out.
Results
Table 1 describes genetic variation observed by analyzing complete sequences of the gene encoding the AMA-1. In addition, we have included published sequences in the analysis [11], [12], [13], [18]. π is a measure of genetic polymorphism that estimates the average number of substitutions between any two sequences. The overall genetic diversity in 44 sequences (π=0.01402) is lower than we reported earlier using a smaller sample size (π=0.01635) [10], indicating that the earlier estimation was
Discussion
The AMA-1 protein is considered an important antigen to be included in a multivalent vaccine. Studies based on synthetic peptides have indicated that this vaccine candidate elicits a specific immune response in persons naturally exposed to malaria parasites in western Kenya [8]. A long-term goal of our vaccine-related field studies is to identify naturally immunogenic determinants of key vaccine antigens to assess how the parasite genetic diversity relates to natural immunity. A step in
Acknowledgements
This research is supported by grants from the ‘Consejo Venezolano de Investigaciones Cientı́ficas’, (G97000634) and The National Institutes of Health (R01 GM60740-01) to A.A.E. This work was supported in part by the US Agency for International Development grant HRN-60010-A-00-4010-00 to A.A.L. We thank Oralee Branch, Shannon L. Takala, and Lauren M. Singer for helpful comments on the manuscript.
References (41)
- et al.
The disulfide bond structure of Plasmodium Apical Membrane Antigen-1
J. Biol. Chem.
(1996) - et al.
Genetic conservation of the Plasmodium falciparum apical membrane antigen-1 (AMA-1)
Mol. Biochem. Parasitol.
(1996) - et al.
Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum
Mol. Biochem. Parasitol.
(1996) - et al.
A Plasmodium falciparum apical membrane antigen-1 (AMA-1) gene apparently generated by intragenic recombination
Mol. Biochem. Parasitol.
(1999) - et al.
Molecular characterisation of Plasmodium reichenowi apical membrane antigen-1 (AMA-1), comparison with P. Falciparum AMA-1, and antibody-mediated inhibition of red cell invasion
Mol. Biochem. Parasitol.
(2000) - et al.
Evolution of protein molecules
- et al.
Natural selection on Plasmodium surface proteins
Mol. Biochem. Parasitol.
(1995) - World Health Organization Tropical Disease Research. TDR Twelfth Program Report, 1997. p....
- et al.
Pathways and strategies for developing a malaria blood-stage vaccine
Annu. Rev. Immunol.
(1998) - et al.
Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population
Am. J. Trop. Med. Hyg.
(1999)
Vaccination trials in rhesus monkeys with a minor, invariant, Plasmodium knowlesi 66 kDa merozoite antigen
Parasite Immunol.
Protective immune responses to apical membrane antigen-1 of Plasmodium chabaudi involve recognition of strain-specific epitopes
Infect. Immun.
High-level expression of Plasmodium vivax apical membrane antigen 1 (AMA-1) in Pichia pastoris: strong immunogenicity in Macaca mulatta immunized with immunized with P. vivax AMA-1 and adjuvant SBAS2
Infect. Immun.
Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria
Infect. Immun.
Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum
Genetics
Analysis of variation in PF83, an erythrocytic merozoite vaccine candidate antigen of Plasmodium falciparum
Mol. Biochem. Parasitol.
DNA sequence variation at the period locus within and among species of the Drosophila melanogaster complex
Genetics
Phylogeny of the malarial genus Plasmodium, derived from ribosomal gene sequences
Proc. Nat. Acad. Sci. USA
The evolution of primate malaria parasites based on the gene encoding cytochrome b from the linear mitochondrial genome
Proc. Nat. Acad. Sci. USA
Integral membrane protein located in the apical complex of Plasmodium falciparum
Mol. Cell. Biol.
Cited by (106)
Population genetic structure analysis of thrombospondin-related adhesive protein (TRAP) as a vaccine candidate antigen in worldwide Plasmodium falciparum isolates
2020, Infection, Genetics and EvolutionCitation Excerpt :As per this analysis, a positive/balancing selection was observed across pftrap sequences (mostly in DII and IV) in all the studied populations, which indicates that the mentioned domains of this gene is under immune system pressure, and these replacements will probably provide a way for the parasite to escape from host immune responses. The extent of nucleotide diversity is correlated with the transmission intensity of malaria in endemic areas (Escalante et al., 2001; Garg et al., 2007). The analysis of nucleotide diversity revealed the lowest values of diversity in pftrap sequences from Iranian and French Guianan isolates but, the highest values in isolates from African populations in different settings, as the hyper-endemic areas of Africa.
Comparative sequence analysis of domain I of Plasmodium falciparum apical membrane antigen 1 from Saudi Arabia and worldwide isolates
2016, Infection, Genetics and EvolutionCitation Excerpt :These contradicting results could stem from differences in the extent of sequence diversity and functional constraints of these genes. The extent of nucleotide polymorphism seems to be related to transmission intensity and the prevalence of malaria in each geographical region (Escalante et al., 2001; Garg et al., 2007). However, the extent of nucleotide diversity in the PfAMA1 gene of Saudi Arabian isolates observed in this study was comparable to those of African origins (The Gambia, Ghana, Mali and Tanzania) despite differences in intensity of malaria transmission between these regions.